Dynamics Special Purpose Corp. Contracts & Agreements

Sublease Agreement by and between Senti Biosciences, Inc. and GeneFab, LLC, dated August 7, 2023 (Filed With SEC on November 14, 2023)

Development and Manufacturing Services Agreement between Senti Biosciences, Inc. and GeneFab, LLC, dated August 7, 2023 (Filed With SEC on November 14, 2023)

Seller Economic Share Agreement by and between Senti Biosciences, Inc., GeneGab, LLC, and Valere Bio, Inc., dated August 7, 2023 (Filed With SEC on November 14, 2023)

Framework Agreement by and between Senti Biosciences, Inc., GeneFab, LLC, and Velere Bio, Inc., dated August 7, 2023 (Filed With SEC on November 14, 2023)

Employee Offer Letter by and between Kanya Rajangam and Senti Biosciences, Inc., dated May 10, 2022 (Filed With SEC on May 9, 2023)

Research and Development and Laboratory Lease Agreement, by and between 1430 Harbor Bay Pkwy LLC and Senti Biosciences, Inc., dated June 3, 2021 (Filed With SEC on March 22, 2023)

Description of Securities (Filed With SEC on March 22, 2023)

Amendment No. 1 to the Research and License Agreement between Spark Therapeutics, Inc. and Senti Biosciences, Inc., dated December 8, 2022 (Filed With SEC on March 22, 2023)

Side Letter between BlueRock Therapeutics, LP and Senti Biosciences, Inc., dated February 3, 2023 (Filed With SEC on March 22, 2023)

Scientific Advisory Board Agreement between Senti Biosciences, Inc. and James Collins (Filed With SEC on March 22, 2023)

Senti Biosciences, Inc. 2022 Inducement Plan and form of award agreements thereunder (Filed With SEC on November 10, 2022)

Severance and Change in Control Agreement between the Company and Tim Lu (Filed With SEC on November 10, 2022)

Severance and Change in Control Agreement between the Company and Philip Lee (Filed With SEC on November 10, 2022)

Severance and Change in Control Agreement between the Company and Deborah Knobelman (Filed With SEC on November 10, 2022)

Consulting Agreement between Senti Biosciences, Inc. and David Epstein (Filed With SEC on November 10, 2022)

Non-Employee Director Compensation Policy (Filed With SEC on November 10, 2022)

Senti Biosciences, Inc. 2022 Inducement Plan and forms of award agreements thereunder (Filed With SEC on September 12, 2022)

Registration Rights Agreement dated as of August (Filed With SEC on September 1, 2022)

ChEF Purchase Agreement, dated as of August 31, 2022, by and between Senti Biosciences, Inc. and Chardan Capital Markets LLC (Filed With SEC on September 1, 2022)

Senti Biosciences, Inc. 2022 Employee Stock Purchase Plan (Filed With SEC on August 15, 2022)

Senti Biosciences, Inc. 2022 Stock Option and Incentive Plan and forms of award agreements thereunder (Filed With SEC on August 15, 2022)

Investor Rights and Lock-up Agreement (Filed With SEC on June 15, 2022)

Specimen Common Stock Certificate (Filed With SEC on June 15, 2022)

Convertible Promissory Note by and between Senti, the Company and Bayer HealthCare LLC, dated as of May 19, 2022 (Filed With SEC on May 24, 2022)

Note Subscription Agreement by and among Senti, the Company and Bayer HealthCare LLC, dated as of May 19, 2022 (Filed With SEC on May 24, 2022)

Amendment No. 2 to Business Combination Agreement, dated as of May 19, 2022, by and among Dynamics Special Purpose Corp., Explore Merger Sub, Inc., and Senti Biosciences, Inc (Filed With SEC on May 24, 2022)

Form of Amendment No. 1 to Non-Redemption Agreement, dated as of May 9, 2022, by and among Dynamics Sponsor LLC, Dynamics Special Purpose Corp. and the undersigned investor (Filed With SEC on May 10, 2022)

Description of the Registrants securities (Filed With SEC on March 7, 2022)

Second Amendment to Lease, by and between Britannia Biotech Gateway Limited Partnership and Senti Biosciences, Inc., dated June 17, 2020 (Filed With SEC on February 14, 2022)

Form of Amendment to Company Stockholder Support Agreement entered into on February 12, 2022 by certain stockholders of Senti Biosciences, Inc (Filed With SEC on February 14, 2022)

Collaboration and Option Agreement by and between BlueRock Therapeutics, LP and Senti Biosciences, Inc., dated May 21, 2021 (Filed With SEC on February 14, 2022)

Patent License Agreement by and between the U.S. Department of Health and Human Services, as represented by the National Cancer Institute, and Senti Biosciences, Inc., dated May... (Filed With SEC on February 14, 2022)

Research Collaboration and License Agreement by and between Spark Therapeutics, Inc. and Senti Biosciences, Inc., dated April 9, 2021 (Filed With SEC on February 14, 2022)

Patent License Agreement by and between the U.S. Department of Health and Human Services, as represented by the National Cancer Institute, and Senti Biosciences, Inc., dated... (Filed With SEC on February 14, 2022)

Patent License Agreement by and between the U.S. Department of Health and Human Services, as represented by the National Cancer Institute, and Senti Biosciences, Inc., dated July... (Filed With SEC on February 14, 2022)

Research and Development and Laboratory Lease Agreement, by and between 1430 Harbor Bay Pkwy LLC and Senti Biosciences, Inc., dated June 3, 2021 (Filed With SEC on February 14, 2022)

First Amendment to Lease, by and between Britannia Biotech Gateway Limited Partnership and Senti Biosciences, Inc., dated May 8, 2019 (Filed With SEC on February 14, 2022)

Lease, by and between Britannia Biotech Gateway Limited Partnership and Senti Biosciences, Inc., dated July 17, 2018 (Filed With SEC on February 14, 2022)

Employee Offer Letter, by and between Deborah Knobelman and Senti Biosciences, Inc., dated May 13, 2021 (Filed With SEC on February 14, 2022)

Employment Agreement, by and between Curt Herberts III and Senti Biosciences, Inc., dated April 28, 2018 (Filed With SEC on February 14, 2022)

Employee Offer Letter, by and between Philip Lee and Senti Biosciences, Inc., dated December 27, 2018 (Filed With SEC on February 14, 2022)

Employee Offer Letter, by and between Timothy Lu and Senti Biosciences, Inc., dated December 27, 2018 (Filed With SEC on February 14, 2022)

Senti Biosciences, Inc. 2016 Stock Incentive Plan, as amended, and forms of award agreements thereunder (Filed With SEC on February 14, 2022)

Amended and Restated Investors Rights Agreement by and among Senti Biosciences, Inc. and certain of its stockholders, dated October 22, 2020 (Filed With SEC on February 14, 2022)

Form of Non-Redemption Agreement (Filed With SEC on December 20, 2021)

Business Combination Agreement, dated as of December 19, 2021, by and among Dynamics Special Purpose Corp., Explore Merger Sub, Inc. and Senti Biosciences, Inc (Filed With SEC on December 20, 2021)

Form of Subscription Agreement (Filed With SEC on December 20, 2021)

Indemnity Agreement, dated May 25, 2021, between the Company and Omid Farokhzad (Filed With SEC on May 28, 2021)

Underwriting Agreement, dated May 25, 2021, between the Company and J.P. Morgan Securities LLC (Filed With SEC on May 28, 2021)

Letter Agreement, dated May 25, 2021 among the Company and its officers, directors and Dynamics Sponsor LLC (Filed With SEC on May 28, 2021)

Investment Management Trust Agreement, dated May 25, 2021, between the Company and Continental Stock Transfer & Trust Company, as trustee (Filed With SEC on May 28, 2021)

Registration Rights Agreement, dated May 25, 2021, between the Company and certain security holders (Filed With SEC on May 28, 2021)

Private Placement Shares Purchase Agreement, dated May 25, 2021 between the Company and Dynamics Sponsor LLC (Filed With SEC on May 28, 2021)

Administrative Services Agreement, dated May 25, 2021, between the Company and Dynamics Sponsor LLC (Filed With SEC on May 28, 2021)

Indemnity Agreement, dated May 25, 2021, between the Company and Mark Afrasiabi (Filed With SEC on May 28, 2021)

Indemnity Agreement, dated May 25, 2021, between the Company and Rowan Chapman (Filed With SEC on May 28, 2021)

Indemnity Agreement, dated May 25, 2021, between the Company and David Epstein (Filed With SEC on May 28, 2021)

Indemnity Agreement, dated May 25, 2021, between the Company and Dipchand Nishar (Filed With SEC on May 28, 2021)

Indemnity Agreement, dated May 25, 2021, between the Company and Jay Flatley (Filed With SEC on May 28, 2021)

Indemnity Agreement, dated May 25, 2021, between the Company and Mostafa Ronaghi (Filed With SEC on May 28, 2021)

Promissory Note issued in favor of Dynamics Sponsor LLC, dated March 8, 2021 (Filed With SEC on May 24, 2021)

Form of Administrative Services Agreement between the Registrant and Dynamics Sponsor LLC (Filed With SEC on May 21, 2021)

Specimen Class A Common Stock Certificate (Filed With SEC on May 21, 2021)

Form of Letter Agreement among the Registrant, Dynamics Sponsor LLC, and each of the officers and directors of the Registrant (Filed With SEC on May 21, 2021)

Form of Investment Management Trust Agreement between Continental Stock Transfer & Trust Company and the Registrant (Filed With SEC on May 21, 2021)

Securities Subscription Agreement, dated March 8, 2021, between the Registrant and Dynamics Sponsor LLC (Filed With SEC on May 21, 2021)

Form of Private Placement Share Purchase Agreement between the Registrant and Dynamics Sponsor LLC (Filed With SEC on May 21, 2021)

Form of Registration and Stockholder Rights Agreement between the Registrant and certain securityholders (Filed With SEC on May 21, 2021)

Form of Indemnity Agreement (Filed With SEC on May 21, 2021)

Promissory Note issued in favor of Dynamics Sponsor LLC, dated March 8, 2021 (Filed With SEC on May 21, 2021)

Form of Underwriting Agreement (Filed With SEC on May 21, 2021)